Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock UTRS vs. VIVE, MOTS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, BRSH, and CTCXWShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Viveve Medical (VIVE), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Bruush Oral Care (BRSH), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry. Minerva Surgical vs. Viveve Medical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Carmell Minerva Surgical (NASDAQ:UTRS) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, community ranking, risk and analyst recommendations. Is UTRS or VIVE more profitable? Company Net Margins Return on Equity Return on Assets Minerva SurgicalN/A N/A N/A Viveve Medical N/A N/A N/A Which has more volatility and risk, UTRS or VIVE? Minerva Surgical has a beta of 3.92, suggesting that its share price is 292% more volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Which has better valuation and earnings, UTRS or VIVE? Viveve Medical has lower revenue, but higher earnings than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMinerva Surgical$51.69M0.00-$34.11MN/AN/AViveve Medical$6.83M0.00N/AN/AN/A Does the MarketBeat Community favor UTRS or VIVE? Viveve Medical received 304 more outperform votes than Minerva Surgical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 41.18% of users gave Minerva Surgical an outperform vote. CompanyUnderperformOutperformMinerva SurgicalOutperform Votes741.18% Underperform Votes1058.82% Viveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% Does the media prefer UTRS or VIVE? In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score. Company Overall Sentiment Minerva Surgical Neutral Viveve Medical Neutral SummaryMinerva Surgical and Viveve Medical tied by winning 2 of the 4 factors compared between the two stocks. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$4.39B$5.57B$7.83BDividend YieldN/A39.98%5.11%4.22%P/E RatioN/A30.6722.4418.48Price / SalesN/A54.91394.09103.59Price / CashN/A51.0838.1834.62Price / BookN/A6.116.774.25Net Income-$34.11M$68.15M$3.22B$248.23M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070MOTSMotus GIN/A$0.00flatN/AN/A$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.22+6.8%N/A-17.2%$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.02-2.6%N/A-62.3%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$20.20flatN/A-29.3%$0.00N/A0.002BRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011Positive NewsBRSHBruush Oral CareN/A$0.00flatN/A-98.6%$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32,839.000.0014Gap Up Related Companies and Tools Related Companies Viveve Medical Alternatives Motus GI Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Assure Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Bruush Oral Care Alternatives Carmell Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTRS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTRS Stock Free UTRS Stock Alerts